**Moderna** ([MRNA](https://ift.tt/QgX7sAb) swung to a loss and posted a steep drop in quarterly sales, weighed down by soft demand for its Covid-19 vaccine. The company also forecast sales of about $4 billion for next year, softer than Wall Street analysts were expecting.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles